Letter: An Update of Neuroanesthesia for Intraoperative Brain Mapping Craniotomy
- PMID: 35377350
- DOI: 10.1227/neu.0000000000001974
Letter: An Update of Neuroanesthesia for Intraoperative Brain Mapping Craniotomy
Comment in
-
In Reply: An Update of Neuroanesthesia for Intraoperative Brain Mapping Craniotomy.Neurosurgery. 2022 Jun 1;90(6):e200. doi: 10.1227/neu.0000000000001975. Epub 2022 Apr 14. Neurosurgery. 2022. PMID: 35411869 No abstract available.
Comment on
-
An Update of Neuroanesthesia for Intraoperative Brain Mapping Craniotomy.Neurosurgery. 2022 Jan 1;90(1):1-6. doi: 10.1093/neuros/nyab022. Neurosurgery. 2022. PMID: 33647962 Review.
References
-
- Lee CZ, Poon CCM. An update of neuroanesthesia for intraoperative brain mapping craniotomy. Neurosurgery. 2021;90(1):1-6.
-
- Deras P, Moulinié G, Maldonado IL, Moritz-Gasser S, Duffau H, Bertram L. Intermittent general anesthesia with controlled ventilation for asleep-awake-asleep brain surgery: a prospective series of 140 gliomas in eloquent areas. Neurosurgery. 2012;71(4):764-771.
-
- Prontera A, Baroni S, Marudi A, et al. Awake craniotomy anesthetic management using dexmedetomidine, propofol, and remifentanil. Drug Des Devel Ther. 2017;11:593-598.
-
- Sato T, Kato Y, Yamamoto M, Nishiwaki K. Novel anesthetic agent remimazolam as an alternative for the asleep-awake-asleep technique of awake craniotomy. JA Clin Rep. 2020;6(1):92.
-
- Antonik LJ, Goldwater DR, Kilpatrick GJ, Tilbrook GS, Borkett KM. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): part I. Safety, efficacy, and basic pharmacokinetics. Anesth Analg. 2012;115(2):274-283.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
